CTRI/2022/01/039863CompletedPhase 2
Preclinical and clinical evaluation of the effect on oral administration of KARUNJEERAKA MATHIRAI along with external application of NUNAA TAILAM in the management of VENPADAI in children
Dr S Surendar0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Hypo pigemented patches surrounded by hyper pigemneted border present in any part of the body
Exclusion Criteria
- •1.Children above 12 years
- •2.Children below 3 years
- •3.Albinism
- •4.Pie-baldism
- •5.Hypo pigmented patches start firstly in lips and genital area
- •6.Depigemented patches after burns
- •7.Juvenile diabetes with vitiligo
Investigators
Similar Trials
Not yet recruiting
Phase 2
Preclinical and Clinical evaluation of the effect on oral administration of PARANGI KASAYAM along with external application of VARMAM THERAPHY in the management of INFANTILE HEMIPLEGIA in childreCTRI/2022/11/046972DR M MUKILA
Completed
Phase 2
Preclinical and clinical evaluation of the effect of siddha classical drug MANITHAKKALI ENNAI (oral administration) in the management of VITAMIN -B COMPLEX DEFICIENCYCTRI/2022/02/039956Dr S Aiswarya40
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug GANTHAGA NEI(oral administration) along with NATHTHAICHOORI TAILAM(external therapy) in the management of CEREBRAL PALSY.CTRI/2022/06/043082Dr P RAJAVATHANA40
Active, not recruiting
Phase 2
Preclinical and clinical evaluation of siddha classical drug MEDATHAARI CHOORANAM (oral administration) and CHITHIRAMOOLA TAILAM (external) in the management of JUVENILE ARTHRITIS.CTRI/2022/01/039856Dr P Ponsridharani
Completed
Phase 2
Preclinical and clinical evaluation of the effect of Siddha classical drug PARUMA NOI NIVARANA MAATHIRAI & NEERMULLI OORAL KUDINEER (oral administration ) along with PODI THIMIRTHAL ( external therapy) in the management of CHILDHOOD OBESITY.CTRI/2022/02/040297Dr J Mangalavalli40
